Metabolism of a novel antitumor agent, crisnatol, by a human hepatoma cell line, Hep G2, and hepatic microsomes: Characterization of metabolites
- 5 July 1991
- journal article
- research article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 42 (2) , 337-346
- https://doi.org/10.1016/0006-2952(91)90721-g
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- [(1-Pyrenylmethyl)amino] alcohols, a new class of antitumor DNA intercalators. Discovery and initial amine side chain structure-activity studiesJournal of Medicinal Chemistry, 1990
- Mixed function oxidase and UDP-glucuronyltransferase activities in the human Hep G2 hepatoma cell lineBiochemical Pharmacology, 1988
- Status of reduced glutathione in the human hepatoma cell line, HEP G2Biochemical Pharmacology, 1988
- Drug metabolism by the human hepatoma cell, Hep G2Biochemical and Biophysical Research Communications, 1987
- Induction of drug metabolizing enzymes in human liver cell line Hep G2FEBS Letters, 1985
- Demonstration that a Human Hepatoma Cell Line Produces a Specific Insulin-Like Growth Factor Carrier Protein*Journal of Clinical Endocrinology & Metabolism, 1983
- Evaluation of a human hepatoma cell line as a target cell in genetic toxicologyMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 1983
- Characterization of the major apolipoproteins secreted by two human hepatoma cell linesBiochemistry, 1981
- Human Hepatocellular Carcinoma Cell Lines Secrete the Major Plasma Proteins and Hepatitis B Surface AntigenScience, 1980
- Controlled synthesis of HBsAg in a differentiated human liver carcinoma-derived cell lineNature, 1979